Marc Frahm
Stock Analyst at TD Cowen
(0.11)
# 3,293
Out of 4,479 analysts
13
Total ratings
16.67%
Success rate
-30.8%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintains: Buy | $88 → $80 | $59.02 | +35.55% | 3 | May 1, 2024 | |
| SANA Sana Biotechnology | Initiates: Market Perform | n/a | $5.35 | - | 1 | Aug 14, 2023 | |
| CGEM Cullinan Oncology | Initiates: Outperform | n/a | $16.31 | - | 1 | Jun 15, 2023 | |
| XLO Xilio Therapeutics | Initiates: Outperform | n/a | $0.89 | - | 1 | Nov 16, 2021 | |
| TBPH Theravance Biopharma | Downgrades: Market Perform | n/a | $8.32 | - | 1 | Aug 24, 2021 | |
| NUVL Nuvalent | Initiates: Outperform | n/a | $73.00 | - | 1 | Aug 23, 2021 | |
| ELEV Elevation Oncology | Initiates: Outperform | n/a | $2.80 | - | 1 | Jul 20, 2021 | |
| JANX Janux Therapeutics | Initiates: Outperform | n/a | $39.30 | - | 1 | Jul 6, 2021 | |
| DAWN Day One Biopharmaceuticals | Initiates: Outperform | n/a | $13.46 | - | 1 | Jun 21, 2021 | |
| INZY Inozyme Pharma | Initiates: Outperform | n/a | $4.42 | - | 1 | Aug 18, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Outperform | n/a | $4.21 | - | 1 | Feb 24, 2020 |
Incyte
May 1, 2024
Maintains: Buy
Price Target: $88 → $80
Current: $59.02
Upside: +35.55%
Sana Biotechnology
Aug 14, 2023
Initiates: Market Perform
Price Target: n/a
Current: $5.35
Upside: -
Cullinan Oncology
Jun 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $16.31
Upside: -
Xilio Therapeutics
Nov 16, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.89
Upside: -
Theravance Biopharma
Aug 24, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $8.32
Upside: -
Nuvalent
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $73.00
Upside: -
Elevation Oncology
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.80
Upside: -
Janux Therapeutics
Jul 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $39.30
Upside: -
Day One Biopharmaceuticals
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $13.46
Upside: -
Inozyme Pharma
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $4.42
Upside: -
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Outperform
Price Target: n/a
Current: $4.21
Upside: -